Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: Results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane
Radlmaier, Albert, Eickenberg, Hans U., Fletcher, Matthew S., Fourcade, Richard O., Santos, José M. Reis, van Aubel, Olav G.J. M., Bono, Aldo V.
Published in The Prostate (01.10.1996)
Published in The Prostate (01.10.1996)
Get full text
Journal Article